 treatment immun defici syndrome-rel kaposi sarcoma bleomycin singl agent nonrandom trial effici toxic bleomycin singl agent treatment non-life-threaten aids-rel kaposi sarcoma KS sixti patient studi progress non-life-threaten aids-rel KS system symptom lymphocyt count thirti patient intramuscular bleomycin mg/d day week other slow continu intraven infus bleomycin day week mean durat therapi month rang month partial respons patient diseas addit patient bleomycin patient therapi patient side effect singl agent good altern therapi aids-rel KS